5-HT precursor loading, but not 5-HT receptor agonists, increases motor function after spinal cord contusion in adult rats

Serotonergic (5-HT) receptors are upregulated following spinal cord transection. Stimulation by administration of serotonergic receptor agonists has been successful in improving hindlimb function. We tested whether this strategy would be successful in incomplete injury models (moderate or severe tho...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Experimental neurology 2010-01, Vol.221 (1), p.68-78
Hauptverfasser: Hayashi, Y., Jacob-Vadakot, S., Dugan, E.A., McBride, S., Olexa, R., Simansky, K., Murray, M., Shumsky, J.S.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 78
container_issue 1
container_start_page 68
container_title Experimental neurology
container_volume 221
creator Hayashi, Y.
Jacob-Vadakot, S.
Dugan, E.A.
McBride, S.
Olexa, R.
Simansky, K.
Murray, M.
Shumsky, J.S.
description Serotonergic (5-HT) receptors are upregulated following spinal cord transection. Stimulation by administration of serotonergic receptor agonists has been successful in improving hindlimb function. We tested whether this strategy would be successful in incomplete injury models (moderate or severe thoracic contusion) where descending projections are partially spared which should produce less denervation-induced receptor upregulation. Adult rats received midthoracic moderate (MOD: 25 mm drop) or severe (SEV: 50 mm drop) contusion injuries. Distribution of 5-HT and its transporter and expression of 5-HT 2C receptors were evaluated in lumbar spinal cord and motor response to 5-HT receptor activation was assessed using open field locomotion (BBB) score, percent weight supported treadmill stepping (%WS) and evaluation of hindlimb muscle activation (tremor and serotonin syndrome). 5-HT immunostaining 3 months post-contusion revealed few 5-HT fibers caudal to the severe contusion, and more spared caudal to the moderate contusion. The distribution of 5-HT transporter paralleled 5-HT staining, but was more greatly reduced. Thus serotonin reuptake may be less efficient in the injured spinal cord. Immunostaining for the 5-HT 2C receptor in the dorsal and ventral horns at L5 showed significant upregulation in SEV, compared to sham or MOD rats. Neither 5-HT 2C nor 5-HT 1A receptor agonists, alone or in combination, nor the serotonin transporter inhibitor d-fenfluramine modified BBB scores or %WS in either group. Despite the increased sensitivity of post-synaptic targets, agonist treatment did not improve function in SEV rats. We conclude that selective 5-HT 2C or 5-HT 1A receptor activation was not effective in improving hindlimb function after incomplete lesions. In contrast, the 5-HT precursor 5-hydroxytryptophan ( l-5-HTP), which leads to activation of all classes of 5-HT receptors, increased both %WS and hindlimb activity in the MOD group. While no side effects were observed in normal or MOD rats, SEV rats displayed hindlimb tremors and 33% mortality, indicating hypersensitivity to the precursor.
doi_str_mv 10.1016/j.expneurol.2009.10.003
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2812640</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0014488609004208</els_id><sourcerecordid>21231099</sourcerecordid><originalsourceid>FETCH-LOGICAL-c535t-3c53fa5af53d2527227f2aa861e53ddb148660cbc4969a37a3e3b37691ae85923</originalsourceid><addsrcrecordid>eNqFkU1v1DAQhi0EokvhL4AvcGoWf-TzglRVQJEqcSlna-JMFq-ydvA4FfDrcdjVAicutjTPM-ORX8ZeSbGVQtZv91v8PntcYpi2SoguV7dC6EdsI0UnClVq8ZhthJBlUbZtfcGeEe1FFkvVPGUXsmtL0bTNhv2sitt7Pke0S6QQ-RRgcH53xfslcR8S_80zxjllDLvgHSW64s7biEBI_BBWMi7eJhc8hzFh5DQ7DxO3IQ758GmhlbmMh2VKPEKi5-zJCBPhi9N9yb58eH9_c1vcff746eb6rrCVrlKh8zVCBWOlB1WpRqlmVABtLTFXhl6WbV0L29uyqzvQDWjUvW7qTgK2Vaf0JXt3nDsv_QEHiz5FmMwc3QHiDxPAmX-Jd1_NLjwY1UpVlyIPeHMaEMO3BSmZgyOL0wQew0JGSaXzt3dZbI6ijYEo4nh-RAqz5mb25pybWXNbQc4td778e8c_faegsvD6JABZmMYI3jo6e0rpSrVKZu_66GH-0QeH0ZB16C0OLoeYzBDcf5f5BZP9vXo</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>21231099</pqid></control><display><type>article</type><title>5-HT precursor loading, but not 5-HT receptor agonists, increases motor function after spinal cord contusion in adult rats</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Hayashi, Y. ; Jacob-Vadakot, S. ; Dugan, E.A. ; McBride, S. ; Olexa, R. ; Simansky, K. ; Murray, M. ; Shumsky, J.S.</creator><creatorcontrib>Hayashi, Y. ; Jacob-Vadakot, S. ; Dugan, E.A. ; McBride, S. ; Olexa, R. ; Simansky, K. ; Murray, M. ; Shumsky, J.S.</creatorcontrib><description>Serotonergic (5-HT) receptors are upregulated following spinal cord transection. Stimulation by administration of serotonergic receptor agonists has been successful in improving hindlimb function. We tested whether this strategy would be successful in incomplete injury models (moderate or severe thoracic contusion) where descending projections are partially spared which should produce less denervation-induced receptor upregulation. Adult rats received midthoracic moderate (MOD: 25 mm drop) or severe (SEV: 50 mm drop) contusion injuries. Distribution of 5-HT and its transporter and expression of 5-HT 2C receptors were evaluated in lumbar spinal cord and motor response to 5-HT receptor activation was assessed using open field locomotion (BBB) score, percent weight supported treadmill stepping (%WS) and evaluation of hindlimb muscle activation (tremor and serotonin syndrome). 5-HT immunostaining 3 months post-contusion revealed few 5-HT fibers caudal to the severe contusion, and more spared caudal to the moderate contusion. The distribution of 5-HT transporter paralleled 5-HT staining, but was more greatly reduced. Thus serotonin reuptake may be less efficient in the injured spinal cord. Immunostaining for the 5-HT 2C receptor in the dorsal and ventral horns at L5 showed significant upregulation in SEV, compared to sham or MOD rats. Neither 5-HT 2C nor 5-HT 1A receptor agonists, alone or in combination, nor the serotonin transporter inhibitor d-fenfluramine modified BBB scores or %WS in either group. Despite the increased sensitivity of post-synaptic targets, agonist treatment did not improve function in SEV rats. We conclude that selective 5-HT 2C or 5-HT 1A receptor activation was not effective in improving hindlimb function after incomplete lesions. In contrast, the 5-HT precursor 5-hydroxytryptophan ( l-5-HTP), which leads to activation of all classes of 5-HT receptors, increased both %WS and hindlimb activity in the MOD group. While no side effects were observed in normal or MOD rats, SEV rats displayed hindlimb tremors and 33% mortality, indicating hypersensitivity to the precursor.</description><identifier>ISSN: 0014-4886</identifier><identifier>EISSN: 1090-2430</identifier><identifier>DOI: 10.1016/j.expneurol.2009.10.003</identifier><identifier>PMID: 19840787</identifier><identifier>CODEN: EXNEAC</identifier><language>eng</language><publisher>Amsterdam: Elsevier Inc</publisher><subject>5-HT 2C receptor ; 5-HT transporter ; 5-Hydroxytryptophan - therapeutic use ; Animals ; Biological and medical sciences ; Carbidopa - pharmacology ; Carbidopa - therapeutic use ; Cervical Vertebrae - pathology ; Disease Models, Animal ; Dose-Response Relationship, Drug ; DPAT ; Drug Administration Routes ; Drug Administration Schedule ; Enzyme Inhibitors - pharmacology ; Enzyme Inhibitors - therapeutic use ; Exercise Test - methods ; Exploratory Behavior - drug effects ; Female ; Fenfluramine ; Hindlimb - drug effects ; Hindlimb - physiopathology ; Injuries of the nervous system and the skull. Diseases due to physical agents ; l-5-HTP ; Laminectomy - adverse effects ; mCPP ; Medical sciences ; Motor Activity - drug effects ; Movement Disorders - drug therapy ; Movement Disorders - etiology ; Neurology ; Rats ; Rats, Sprague-Dawley ; Receptor, Serotonin, 5-HT2C - metabolism ; Serotonin - metabolism ; Serotonin 5-HT2 Receptor Agonists ; Serotonin Plasma Membrane Transport Proteins - metabolism ; Serotonin Receptor Agonists - therapeutic use ; Spinal cord contusion ; Spinal Cord Injuries - complications ; Spinal Cord Injuries - metabolism ; Spinal Cord Injuries - pathology ; Stereotyped Behavior - drug effects ; Time Factors ; Traumas. Diseases due to physical agents ; Tremor - drug therapy ; Tremor - etiology ; Up-Regulation - drug effects</subject><ispartof>Experimental neurology, 2010-01, Vol.221 (1), p.68-78</ispartof><rights>2009 Elsevier Inc.</rights><rights>2015 INIST-CNRS</rights><rights>2009 Elsevier Inc. All rights reserved. 2009</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c535t-3c53fa5af53d2527227f2aa861e53ddb148660cbc4969a37a3e3b37691ae85923</citedby><cites>FETCH-LOGICAL-c535t-3c53fa5af53d2527227f2aa861e53ddb148660cbc4969a37a3e3b37691ae85923</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.expneurol.2009.10.003$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,780,784,885,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=22352821$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19840787$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hayashi, Y.</creatorcontrib><creatorcontrib>Jacob-Vadakot, S.</creatorcontrib><creatorcontrib>Dugan, E.A.</creatorcontrib><creatorcontrib>McBride, S.</creatorcontrib><creatorcontrib>Olexa, R.</creatorcontrib><creatorcontrib>Simansky, K.</creatorcontrib><creatorcontrib>Murray, M.</creatorcontrib><creatorcontrib>Shumsky, J.S.</creatorcontrib><title>5-HT precursor loading, but not 5-HT receptor agonists, increases motor function after spinal cord contusion in adult rats</title><title>Experimental neurology</title><addtitle>Exp Neurol</addtitle><description>Serotonergic (5-HT) receptors are upregulated following spinal cord transection. Stimulation by administration of serotonergic receptor agonists has been successful in improving hindlimb function. We tested whether this strategy would be successful in incomplete injury models (moderate or severe thoracic contusion) where descending projections are partially spared which should produce less denervation-induced receptor upregulation. Adult rats received midthoracic moderate (MOD: 25 mm drop) or severe (SEV: 50 mm drop) contusion injuries. Distribution of 5-HT and its transporter and expression of 5-HT 2C receptors were evaluated in lumbar spinal cord and motor response to 5-HT receptor activation was assessed using open field locomotion (BBB) score, percent weight supported treadmill stepping (%WS) and evaluation of hindlimb muscle activation (tremor and serotonin syndrome). 5-HT immunostaining 3 months post-contusion revealed few 5-HT fibers caudal to the severe contusion, and more spared caudal to the moderate contusion. The distribution of 5-HT transporter paralleled 5-HT staining, but was more greatly reduced. Thus serotonin reuptake may be less efficient in the injured spinal cord. Immunostaining for the 5-HT 2C receptor in the dorsal and ventral horns at L5 showed significant upregulation in SEV, compared to sham or MOD rats. Neither 5-HT 2C nor 5-HT 1A receptor agonists, alone or in combination, nor the serotonin transporter inhibitor d-fenfluramine modified BBB scores or %WS in either group. Despite the increased sensitivity of post-synaptic targets, agonist treatment did not improve function in SEV rats. We conclude that selective 5-HT 2C or 5-HT 1A receptor activation was not effective in improving hindlimb function after incomplete lesions. In contrast, the 5-HT precursor 5-hydroxytryptophan ( l-5-HTP), which leads to activation of all classes of 5-HT receptors, increased both %WS and hindlimb activity in the MOD group. While no side effects were observed in normal or MOD rats, SEV rats displayed hindlimb tremors and 33% mortality, indicating hypersensitivity to the precursor.</description><subject>5-HT 2C receptor</subject><subject>5-HT transporter</subject><subject>5-Hydroxytryptophan - therapeutic use</subject><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Carbidopa - pharmacology</subject><subject>Carbidopa - therapeutic use</subject><subject>Cervical Vertebrae - pathology</subject><subject>Disease Models, Animal</subject><subject>Dose-Response Relationship, Drug</subject><subject>DPAT</subject><subject>Drug Administration Routes</subject><subject>Drug Administration Schedule</subject><subject>Enzyme Inhibitors - pharmacology</subject><subject>Enzyme Inhibitors - therapeutic use</subject><subject>Exercise Test - methods</subject><subject>Exploratory Behavior - drug effects</subject><subject>Female</subject><subject>Fenfluramine</subject><subject>Hindlimb - drug effects</subject><subject>Hindlimb - physiopathology</subject><subject>Injuries of the nervous system and the skull. Diseases due to physical agents</subject><subject>l-5-HTP</subject><subject>Laminectomy - adverse effects</subject><subject>mCPP</subject><subject>Medical sciences</subject><subject>Motor Activity - drug effects</subject><subject>Movement Disorders - drug therapy</subject><subject>Movement Disorders - etiology</subject><subject>Neurology</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>Receptor, Serotonin, 5-HT2C - metabolism</subject><subject>Serotonin - metabolism</subject><subject>Serotonin 5-HT2 Receptor Agonists</subject><subject>Serotonin Plasma Membrane Transport Proteins - metabolism</subject><subject>Serotonin Receptor Agonists - therapeutic use</subject><subject>Spinal cord contusion</subject><subject>Spinal Cord Injuries - complications</subject><subject>Spinal Cord Injuries - metabolism</subject><subject>Spinal Cord Injuries - pathology</subject><subject>Stereotyped Behavior - drug effects</subject><subject>Time Factors</subject><subject>Traumas. Diseases due to physical agents</subject><subject>Tremor - drug therapy</subject><subject>Tremor - etiology</subject><subject>Up-Regulation - drug effects</subject><issn>0014-4886</issn><issn>1090-2430</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkU1v1DAQhi0EokvhL4AvcGoWf-TzglRVQJEqcSlna-JMFq-ydvA4FfDrcdjVAicutjTPM-ORX8ZeSbGVQtZv91v8PntcYpi2SoguV7dC6EdsI0UnClVq8ZhthJBlUbZtfcGeEe1FFkvVPGUXsmtL0bTNhv2sitt7Pke0S6QQ-RRgcH53xfslcR8S_80zxjllDLvgHSW64s7biEBI_BBWMi7eJhc8hzFh5DQ7DxO3IQ758GmhlbmMh2VKPEKi5-zJCBPhi9N9yb58eH9_c1vcff746eb6rrCVrlKh8zVCBWOlB1WpRqlmVABtLTFXhl6WbV0L29uyqzvQDWjUvW7qTgK2Vaf0JXt3nDsv_QEHiz5FmMwc3QHiDxPAmX-Jd1_NLjwY1UpVlyIPeHMaEMO3BSmZgyOL0wQew0JGSaXzt3dZbI6ijYEo4nh-RAqz5mb25pybWXNbQc4td778e8c_faegsvD6JABZmMYI3jo6e0rpSrVKZu_66GH-0QeH0ZB16C0OLoeYzBDcf5f5BZP9vXo</recordid><startdate>20100101</startdate><enddate>20100101</enddate><creator>Hayashi, Y.</creator><creator>Jacob-Vadakot, S.</creator><creator>Dugan, E.A.</creator><creator>McBride, S.</creator><creator>Olexa, R.</creator><creator>Simansky, K.</creator><creator>Murray, M.</creator><creator>Shumsky, J.S.</creator><general>Elsevier Inc</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>5PM</scope></search><sort><creationdate>20100101</creationdate><title>5-HT precursor loading, but not 5-HT receptor agonists, increases motor function after spinal cord contusion in adult rats</title><author>Hayashi, Y. ; Jacob-Vadakot, S. ; Dugan, E.A. ; McBride, S. ; Olexa, R. ; Simansky, K. ; Murray, M. ; Shumsky, J.S.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c535t-3c53fa5af53d2527227f2aa861e53ddb148660cbc4969a37a3e3b37691ae85923</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>5-HT 2C receptor</topic><topic>5-HT transporter</topic><topic>5-Hydroxytryptophan - therapeutic use</topic><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Carbidopa - pharmacology</topic><topic>Carbidopa - therapeutic use</topic><topic>Cervical Vertebrae - pathology</topic><topic>Disease Models, Animal</topic><topic>Dose-Response Relationship, Drug</topic><topic>DPAT</topic><topic>Drug Administration Routes</topic><topic>Drug Administration Schedule</topic><topic>Enzyme Inhibitors - pharmacology</topic><topic>Enzyme Inhibitors - therapeutic use</topic><topic>Exercise Test - methods</topic><topic>Exploratory Behavior - drug effects</topic><topic>Female</topic><topic>Fenfluramine</topic><topic>Hindlimb - drug effects</topic><topic>Hindlimb - physiopathology</topic><topic>Injuries of the nervous system and the skull. Diseases due to physical agents</topic><topic>l-5-HTP</topic><topic>Laminectomy - adverse effects</topic><topic>mCPP</topic><topic>Medical sciences</topic><topic>Motor Activity - drug effects</topic><topic>Movement Disorders - drug therapy</topic><topic>Movement Disorders - etiology</topic><topic>Neurology</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>Receptor, Serotonin, 5-HT2C - metabolism</topic><topic>Serotonin - metabolism</topic><topic>Serotonin 5-HT2 Receptor Agonists</topic><topic>Serotonin Plasma Membrane Transport Proteins - metabolism</topic><topic>Serotonin Receptor Agonists - therapeutic use</topic><topic>Spinal cord contusion</topic><topic>Spinal Cord Injuries - complications</topic><topic>Spinal Cord Injuries - metabolism</topic><topic>Spinal Cord Injuries - pathology</topic><topic>Stereotyped Behavior - drug effects</topic><topic>Time Factors</topic><topic>Traumas. Diseases due to physical agents</topic><topic>Tremor - drug therapy</topic><topic>Tremor - etiology</topic><topic>Up-Regulation - drug effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hayashi, Y.</creatorcontrib><creatorcontrib>Jacob-Vadakot, S.</creatorcontrib><creatorcontrib>Dugan, E.A.</creatorcontrib><creatorcontrib>McBride, S.</creatorcontrib><creatorcontrib>Olexa, R.</creatorcontrib><creatorcontrib>Simansky, K.</creatorcontrib><creatorcontrib>Murray, M.</creatorcontrib><creatorcontrib>Shumsky, J.S.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Experimental neurology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hayashi, Y.</au><au>Jacob-Vadakot, S.</au><au>Dugan, E.A.</au><au>McBride, S.</au><au>Olexa, R.</au><au>Simansky, K.</au><au>Murray, M.</au><au>Shumsky, J.S.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>5-HT precursor loading, but not 5-HT receptor agonists, increases motor function after spinal cord contusion in adult rats</atitle><jtitle>Experimental neurology</jtitle><addtitle>Exp Neurol</addtitle><date>2010-01-01</date><risdate>2010</risdate><volume>221</volume><issue>1</issue><spage>68</spage><epage>78</epage><pages>68-78</pages><issn>0014-4886</issn><eissn>1090-2430</eissn><coden>EXNEAC</coden><abstract>Serotonergic (5-HT) receptors are upregulated following spinal cord transection. Stimulation by administration of serotonergic receptor agonists has been successful in improving hindlimb function. We tested whether this strategy would be successful in incomplete injury models (moderate or severe thoracic contusion) where descending projections are partially spared which should produce less denervation-induced receptor upregulation. Adult rats received midthoracic moderate (MOD: 25 mm drop) or severe (SEV: 50 mm drop) contusion injuries. Distribution of 5-HT and its transporter and expression of 5-HT 2C receptors were evaluated in lumbar spinal cord and motor response to 5-HT receptor activation was assessed using open field locomotion (BBB) score, percent weight supported treadmill stepping (%WS) and evaluation of hindlimb muscle activation (tremor and serotonin syndrome). 5-HT immunostaining 3 months post-contusion revealed few 5-HT fibers caudal to the severe contusion, and more spared caudal to the moderate contusion. The distribution of 5-HT transporter paralleled 5-HT staining, but was more greatly reduced. Thus serotonin reuptake may be less efficient in the injured spinal cord. Immunostaining for the 5-HT 2C receptor in the dorsal and ventral horns at L5 showed significant upregulation in SEV, compared to sham or MOD rats. Neither 5-HT 2C nor 5-HT 1A receptor agonists, alone or in combination, nor the serotonin transporter inhibitor d-fenfluramine modified BBB scores or %WS in either group. Despite the increased sensitivity of post-synaptic targets, agonist treatment did not improve function in SEV rats. We conclude that selective 5-HT 2C or 5-HT 1A receptor activation was not effective in improving hindlimb function after incomplete lesions. In contrast, the 5-HT precursor 5-hydroxytryptophan ( l-5-HTP), which leads to activation of all classes of 5-HT receptors, increased both %WS and hindlimb activity in the MOD group. While no side effects were observed in normal or MOD rats, SEV rats displayed hindlimb tremors and 33% mortality, indicating hypersensitivity to the precursor.</abstract><cop>Amsterdam</cop><pub>Elsevier Inc</pub><pmid>19840787</pmid><doi>10.1016/j.expneurol.2009.10.003</doi><tpages>11</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0014-4886
ispartof Experimental neurology, 2010-01, Vol.221 (1), p.68-78
issn 0014-4886
1090-2430
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2812640
source MEDLINE; Access via ScienceDirect (Elsevier)
subjects 5-HT 2C receptor
5-HT transporter
5-Hydroxytryptophan - therapeutic use
Animals
Biological and medical sciences
Carbidopa - pharmacology
Carbidopa - therapeutic use
Cervical Vertebrae - pathology
Disease Models, Animal
Dose-Response Relationship, Drug
DPAT
Drug Administration Routes
Drug Administration Schedule
Enzyme Inhibitors - pharmacology
Enzyme Inhibitors - therapeutic use
Exercise Test - methods
Exploratory Behavior - drug effects
Female
Fenfluramine
Hindlimb - drug effects
Hindlimb - physiopathology
Injuries of the nervous system and the skull. Diseases due to physical agents
l-5-HTP
Laminectomy - adverse effects
mCPP
Medical sciences
Motor Activity - drug effects
Movement Disorders - drug therapy
Movement Disorders - etiology
Neurology
Rats
Rats, Sprague-Dawley
Receptor, Serotonin, 5-HT2C - metabolism
Serotonin - metabolism
Serotonin 5-HT2 Receptor Agonists
Serotonin Plasma Membrane Transport Proteins - metabolism
Serotonin Receptor Agonists - therapeutic use
Spinal cord contusion
Spinal Cord Injuries - complications
Spinal Cord Injuries - metabolism
Spinal Cord Injuries - pathology
Stereotyped Behavior - drug effects
Time Factors
Traumas. Diseases due to physical agents
Tremor - drug therapy
Tremor - etiology
Up-Regulation - drug effects
title 5-HT precursor loading, but not 5-HT receptor agonists, increases motor function after spinal cord contusion in adult rats
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-20T20%3A39%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=5-HT%20precursor%20loading,%20but%20not%205-HT%20receptor%20agonists,%20increases%20motor%20function%20after%20spinal%20cord%20contusion%20in%20adult%20rats&rft.jtitle=Experimental%20neurology&rft.au=Hayashi,%20Y.&rft.date=2010-01-01&rft.volume=221&rft.issue=1&rft.spage=68&rft.epage=78&rft.pages=68-78&rft.issn=0014-4886&rft.eissn=1090-2430&rft.coden=EXNEAC&rft_id=info:doi/10.1016/j.expneurol.2009.10.003&rft_dat=%3Cproquest_pubme%3E21231099%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=21231099&rft_id=info:pmid/19840787&rft_els_id=S0014488609004208&rfr_iscdi=true